在患有急性淋巴细胞白血病的儿科患者中出现脑血管并发症
Agata Rocka1, Maria Lesniak2, Patrycja Majka2
1Department of Pediatric Radiology, Medical University of Lublin, Al. Racławickie 1, 20-059, Lublin, Poland. agatarocka2@gmail.com.
Scientific reports
|November 19, 2025
概括
脑血管并发症,包括和缺血事件,影响超过12%的急性淋巴细胞白血病 (ALL) 的儿童,主要是在诱导治疗期间. 使用MRI早期检测对于管理这些中枢神经系统 (CNS) 问题至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经学 神经学
- 血液学 血液学 血液学
背景情况:
- 急性淋巴细胞白血病 (ALL) 是最常见的儿科癌症.
- 中枢神经系统 (CNS) 的并发症发生在约10%的儿科ALL病例中.
研究的目的:
- 分析儿科ALL患者中脑血管并发症的发生率和特征.
- 在这个群体中,确定与中枢神经系统并发症相关的关键症状和诊断结果.
主要方法:
- 在2014年至2023年期间治疗的144名儿科ALL患者的回顾性分析.
- 使用PQStat软件进行统计分析.
- 对患者数据的审查,包括人口统计,治疗阶段,症状和诊断成像 (MRI).
主要成果:
- 12.5%的儿科ALL患者发生了脑血管并发症.
- 在诱导治疗期间,并发症最常见 (83.3%).
- 发作 (50%) 和意识受损 (39%) 是最常见的症状;MRI在44.4%的受影响患者中显示出缺血事件.
结论:
- 中枢神经系统并发症是儿科ALL的一个重大问题,特别是在诱导治疗期间.
- 发作和缺血事件是常见的表现,需要及时诊断.
- 核磁共振对早期检测至关重要,需要进一步的研究来最大限度地减少神经毒性.
相关概念视频
Bone Marrow Sampling and Transplants
845
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
845
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247


